{"schema_version":"1","generated_at":"2026-10-28T17:34:52.048Z","data_as_of":null,"url":"https://www.findmykol.com/kol/ann-silk","json_url":"https://www.findmykol.com/kol/ann-silk/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"ann-silk","name":"Ann Silk","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Harvard University","institution_url":"https://www.findmykol.com/institution/harvard-university","city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1477717106","orcid":"0000-0003-3877-3984","openalex":"A5041474007"},"summary":"Ann Silk is an Oncology physician affiliated with Harvard University. OpenAlex indexes 232 publications with 6,396 citations (h-index 35); ClinicalTrials.gov lists 4 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":232,"cited_by_count":6396,"h_index":35,"latest_activity_year":2026,"source":"works"},"trials":{"count":4,"shown":3,"withheld":1,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07426484","title":"Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy","phase":"PHASE4","status":"RECRUITING","role":"Overall official","sponsor":"Dana-Farber Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT07426484","trial_url":"https://www.findmykol.com/trial/NCT07426484"},{"nct":"NCT07100925","title":"A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma","phase":"PHASE1","status":"WITHDRAWN","role":"Overall official","sponsor":"Ankyra Therapeutics, Inc","source_url":"https://clinicaltrials.gov/study/NCT07100925","trial_url":"https://www.findmykol.com/trial/NCT07100925"},{"nct":"NCT04899921","title":"Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Dana-Farber Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT04899921","trial_url":"https://www.findmykol.com/trial/NCT04899921"}],"source":"trials"},"payments":{"company_count":9,"program_years":{"first":2021,"last":null},"rows_total":12,"shown":3,"withheld":9,"rows":[{"payer":"SUN PHARMACEUTICAL INDUSTRIES INC.","program_year":2025,"amount_usd":27862.78,"payment_count":26,"source_url":"https://openpaymentsdata.cms.gov/search?query=1477717106"},{"payer":"Regeneron Healthcare Solutions, Inc.","program_year":2025,"amount_usd":25957.36,"payment_count":31,"source_url":"https://openpaymentsdata.cms.gov/search?query=1477717106"},{"payer":"Immunocore Limited","program_year":2025,"amount_usd":2400,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1477717106"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1477717106","source":"payments"},"funding":{"award_count":1,"fiscal_years":{"first":2026,"last":2026},"rows_total":1,"shown":1,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R13AR088535","title":"The Fourth International Merkel Cell Carcinoma Symposium","fiscal_year":2026,"amount_usd":"25000","organization":"DANA-FARBER CANCER INST","source_url":"https://reporter.nih.gov/quickSearch/R13AR088535"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision","year":2024,"journal":"Journal for ImmunoTherapy of Cancer","source_url":"https://doi.org/10.1136/jitc-2024-009063","status":"verified"},{"title":"Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.23.01498","status":"verified"},{"title":"A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6","year":2024,"journal":"Journal of the American Academy of Dermatology","source_url":"https://doi.org/10.1016/j.jaad.2024.06.108","status":"verified"},{"title":"Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.23.02054","status":"verified"},{"title":"Neoadjuvant-Intent Immunotherapy in Advanced, Resectable Cutaneous Squamous Cell Carcinoma","year":2024,"journal":"JAMA Otolaryngology–Head & Neck Surgery","source_url":"https://doi.org/10.1001/jamaoto.2024.0259","status":"verified"}],"source":"works"},"contact":{"address_1":"450 BROOKLINE AVE","city":"Boston","state":"MA","zip":"022155450","phone":"617-632-6140","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1477717106","source":"identity"},"similar":[{"name":"Felipe Fregni","slug":"felipe-fregni","institution":"Harvard University","specialty":"Neurology","url":"https://www.findmykol.com/kol/felipe-fregni","json_url":"https://www.findmykol.com/kol/felipe-fregni/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Sarah Fortune","slug":"sarah-fortune","institution":"Harvard University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/sarah-fortune","json_url":"https://www.findmykol.com/kol/sarah-fortune/profile.json"},{"name":"Ethan Lerner","slug":"ethan-lerner","institution":"Harvard University","specialty":"Dermatology","url":"https://www.findmykol.com/kol/ethan-lerner","json_url":"https://www.findmykol.com/kol/ethan-lerner/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":1,"payments":9,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2019-02-14","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}